April 25, 2024 marks the seventh annual European Alpha-1 Awareness Day, a date in which those afflicted with the genetic condition Alpha-1 Antitrypsin Deficiency (AATD) come together as one community to share their stories, experiences and hardships. The goal of this Awareness Day is to provide information on this genetic condition in order to achieve increased rates of detection and diagnosis, and ultimately achieve greater access to treatment for those affected by AATD.
Today, on #EuropeanAlpha1AwarenessDay, we remind all of the importance of testing. Particularly, all patients with unexplained liver disease, and those experiencing frequent respiratory infections should seek testing. Additionally, individuals with a family history of alpha-1 antitrypsin deficiency, those living with COPD, bronchiectasis, or irreversible asthma should also undergo screening. Don’t wait for symptoms to worsen – get tested now!
